Condensed 3‐day BrECADD and time toxicity: Several roads to cure in advanced‐stage Hodgkin lymphoma
British Journal of Haematology · 29.10.2026
DOI: 10.1111/bjh.70918 ↗Kurz gefasst
Leserbrief in der Zeitschrift British Journal of Haematology, online erschienen am 29.10.2026. Verfasst von Christian Peter Jaworek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hosp…. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
- German Hodgkin Study Group (GHSG), Cologne, Germany.
- Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
ORCID-Profile: Christian Peter Jaworek, Peter Borchmann, Bastian von Tresckow
Zitieren
APA
Jaworek, C. P., Borchmann, P., & von Tresckow, B. (2026). Condensed 3‐day BrECADD and time toxicity: Several roads to cure in advanced‐stage Hodgkin lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.70918
Vancouver
Jaworek CP, Borchmann P, von Tresckow B. Condensed 3‐day BrECADD and time toxicity: Several roads to cure in advanced‐stage Hodgkin lymphoma. British Journal of Haematology. 2026. doi:10.1111/bjh.70918
BibTeX
@article{Jaworek2026,
author = {Jaworek, Christian Peter and Borchmann, Peter and von Tresckow, Bastian},
title = {Condensed 3‐day BrECADD and time toxicity: Several roads to cure in advanced‐stage Hodgkin lymphoma},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70918}
}
EUVIMED